Fulgent Genetics, Inc. Common Stock
FLGT Real Time Price USDRecent trades of FLGT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by FLGT's directors and management
Government lobbying spending instances
-
$60,000 Apr 22, 2024 Issue: Health Issues
-
$50,000 Jan 20, 2023 Issue: Health Issues
-
$100,000 Oct 20, 2022 Issue: Health Issues
-
$20,000 Oct 19, 2022 Issue: Health Issues
Estimated quarterly lobbying spending
FLGT Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to FLGT
Number of mentions of FLGT in WallStreetBets Daily Discussion
Recent picks made for FLGT stock on CNBC
ETFs with the largest estimated holdings in FLGT
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $FLGT stock a Buy, Sell, or Hold?
- What is the price target for $FLGT stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $FLGT stock?
- Who owns the most shares of $FLGT stock?
- What funds own $FLGT stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view FLGT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.